Researchers at the University of Geneva (UNIGE) have deciphered a cellular mechanism leading to the desynchronization of neural networks, and corrected this organizational defect in an adult schizophrenia animal model, thereby suppressing abnormal behaviours associated with the condition.
The findings show that a therapeutic intervention is possible at all ages.
Schizophrenia, an often severe and disabling psychiatric disorder, affects approximately 1 percent of the world’s population. While research over the past few years has suggested that desynchronization of neurons may be the cause of its neuropsychiatric symptoms, including memory disorders, hyperactivity and hallucinatory phenomena, the cellular origin of such desynchronization remains poorly understood.
22q11 Deletion Syndrome
Schizophrenia, which has clinical manifestations that may differ from one patient to another, is a neurodevelopmental disease characterized by many cognitive and behavioural symptoms, including visual or auditory hallucinations, memory and planning issues, or hyperactivity. While the exact cause of this highly disabling disease is not yet known, certain genetic mutations greatly increase its risk.
For example, individuals affected by the DiGeorge syndrome are 40 times more likely to develop schizophrenic disorders than the general population. The DiGeorge syndrome, also known as the 22q11 deletion syndrome, is a human genetic abnormality marked by the absence of about 30 genes on one of the two copies of chromosome 22.
“What happens in the brains of patients suffering from these behavioural changes characteristic of the disease? Our aim was not only to understand how their neural networks dysfunctions, but also to figure out whether it was possible to restore their normal functioning, especially in adults,"
explains Alan Carleton, professor in the Department of Basic Neurosciences at the Faculty of Medicine of the UNIGE, who directed this work.
Hippocampal Neuronal Networks
The Geneva neuroscientists chose to focus on neural networks of the hippocampus, a brain structure notably involved in memory. They studied a mouse model that reproduces the genetic alteration of DiGeorge syndrome as well as some behavioural changes associated with schizophrenia.
In the hippocampus of a control mouse, the thousands of neurons that make up the network coordinate according to a very precise sequence of activity, which is dynamic in time and synchronized. However, in the neural networks of their mouse models, the scientists observed something completely different.
The neurons showed the same level of activity as in control animals, but without any coordination, as if these cells were incapable of communicating properly with each other.
“The organization and synchronization of neural networks is achieved through the intervention of subpopulations of inhibitory neurons, including parvalbumin neurons. However, in this animal model of schizophrenia, these neurons are much less active. Without proper inhibition to control and structure the electrical activity of other neurons in the network, anarchy rules,"
The second step was to try to restore the synchronization necessary for neural networks to function properly. To do this, the scientists specifically targeted the parvalbumin neurons of the hippocampus.
By stimulating these dysfunctional inhibitory neurons, they managed to restore the sequential organization and normal functioning of neural networks. Similarly, they were able to correct some behavioural abnormalities in these schizophrenia mouse models, suppressing both hyperactivity and memory deficit.
These very positive results suggest that a therapeutic intervention is possible, even in adulthood.
“This is really essential. Indeed, schizophrenia develops in late adolescence, although the neural alterations are most likely present at the neurodevelopmental stage. According to our results, reinforcing the action of a poorly active inhibitory neuron, even after the brain has developed, could be sufficient to restore the proper functioning of these neural networks, thus making certain pathological behaviours disappear,"
Current treatments for schizophrenia are primarily based on the administration of antipsychotic drugs targeting the dopaminergic and serotoninergic systems. In spite of their positive effect on hallucinatory symptoms, they remain less effective to improve many symptoms, and in particular cognitive symptoms.
An approach aiming at overcoming the defect of parvalbumin neurons to increase their inhibitory effect therefore appears to be a promising target; nevertheless, time will be needed before a treatment based on this strategy is developed. The neuroscientists now want to confirm their results by extending their research to schizophrenia resulting from genetic alterations different from those of DiGeorge syndrome.
Thomas Marissal, Rodrigo F. Salazar, Cristina Bertollini, Sophie Mutel, Mathias De Roo, Ivan Rodriguez, Dominique Müller & Alan Carleton Restoring wild-type-like CA1 network dynamics and behavior during adulthood in a mouse model of schizophrenia Nature Neuroscience (2018)